Ningzhe Zhang

Biography

Ningzhe is one of the world’s leaders in neurodegenerative stem cell modeling with 15 years of experience developing cutting-edge iPSC and rodent models of neurodegeneration. Ningzhe was the first scientist to genetically correct Huntington disease in a patient derived stem cell model. He has led industry collaborations with Novartis and BioMarin that have resulted in drugs now in active development. Ningzhe has co-authored over ten publications in journals such as Neuron and Cell Stem Cell. He received his Ph.D. from University of Rochester and spent ten years in Lisa Ellerby’s group as a postdoctoral fellow and staff scientist at Buck Institute for Research on Aging, focusing on understanding and treating Huntington disease with cutting edge technologies such as iPSC models, high throughput screening and CRISPR genome editing.

Research Interest

computational biology